載入...
Site-Specific Antibody Conjugation for ADC and Beyond
Antibody-drug conjugates (ADCs) have become a promising class of antitumor agents with four conjugates being approved by regulatory agencies for treating cancer patients. To improve the conventional conjugations that are currently applied to generate these heterogeneous products, various site-specif...
Na minha lista:
| 發表在: | Biomedicines |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5744088/ https://ncbi.nlm.nih.gov/pubmed/29120405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines5040064 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|